Search

for
Search:

GlossaryLiraglutide

medication mimicking GLP-1 hormone to regulate blood sugar

Liraglutide is a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1) to help regulate blood sugar levels and appetite. It is commonly used to treat type 2 diabetes under the brand name Victoza and for weight management under the brand name Saxenda.

Related Terms

Research

5 / 246 results

Short-Term Combined Treatment With Liraglutide and Metformin Leads to Significant Weight Loss in Obese Women With Polycystic Ovary Syndrome and Previous Poor Response to Metformin

research Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

116 citations , December 2013 in “European journal of endocrinology”

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

A 12-Week Treatment with the Long-Acting Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Leads to Significant Weight Loss in a Subset of Obese Women with Newly Diagnosed Polycystic Ovary Syndrome

research A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome

61 citations , January 2015 in “Hormones”

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa: A Case Report

research A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report

9 citations , July 2017 in “Case Reports in Dermatology”

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

research Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review

1 citations , August 2025

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Effects of Liraglutide on Visceral Adiposity Index in Women of Reproductive Age with Prediabetes

research EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES

January 2024 in “Wiadomości Lekarskie”

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

View more "liraglutide" in research →

Learn

— no results

Try a deeper search in learn →

Community Join

— no results

Try a deeper search in community →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →